Table 1 Patient characteristics (Intent-to-treat population)
From: Psychometric evaluation of a visual analog scale for the assessment of anxiety
Treatment Arm | |||
|---|---|---|---|
Placebo ( n = 57) | Paroxetine ( n = 55) | Lorazepam ( n = 55) | |
Gender (n, %) | |||
Male | 26, 45.6% | 24, 43.6% | 20, 36.4% |
Female | 31, 54.4% | 31, 56.4% | 35, 63.6% |
Race (n, %) | |||
White | 42, 73.7% | 40, 72.7% | 40, 72.7% |
Black | 3, 5.3% | 3, 5.5% | 3, 5.5% |
Hispanic | 9, 15.8% | 6, 10.9% | 8, 14.4% |
Other | 3, 5.3% | 6, 10.9% | 4, 7.2% |
Age in years (mean, SD) | 35.0, 10.4 | 34.7, 12.6 | 38.5, 12.1 |
Baseline HAM-A (mean, SD) | 24.2, 5.0 | 23.4, 3.3 | 24.2, 3.5 |